Fetal Therapy Technologies is a microsurgical device company developing purpose-built tools for delicate fetal surgery, including a platform port designed to provide safer access to the uterus. Working with the Johns Hopkins Center for Fetal Therapy, the company combines clinical insight and engineering research to reduce damage to the amniotic membranes and help lower the risk of preterm birth. Its co-founders, CEO Selena Shirkin and CTO Eric McAlexander, lead a team spanning model creation and regulatory development.